Suppr超能文献

与新型冠状病毒肺炎后综合征相关运动不耐受中的心肺血流动力学差异表型

Differential cardiopulmonary haemodynamic phenotypes in PASC-related exercise intolerance.

作者信息

Kahn Peter A, Joseph Phillip, Heerdt Paul M, Singh Inderjit

机构信息

Yale School of Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, New Haven, CT, USA.

Department of Anesthesiology, Division of Applied Hemodynamics, Yale New Haven Hospital and Yale School of Medicine, New Haven, CT, USA.

出版信息

ERJ Open Res. 2024 Feb 12;10(1). doi: 10.1183/23120541.00714-2023. eCollection 2024 Jan.

Abstract

BACKGROUND

Post-acute sequelae of COVID-19 (PASC) affect a significant proportion of patients who have previously contracted SARS-CoV-2, with exertional intolerance being a prominent symptom. This study aimed to characterise the invasive haemodynamic abnormalities of PASC-related exertional intolerance using invasive cardiopulmonary exercise testing (iCPET).

STUDY DESIGN AND INTERVENTION

55 patients were recruited from the Yale Post-COVID-19 Recovery Program, with most experiencing mild acute illness. Supine right heart catheterisation and iCPET were performed on all participants.

MAIN RESULTS

The majority (75%) of PASC patients exhibited impaired peak systemic oxygen extraction (pEO) during iCPET in conjunction with supranormal cardiac output (CO) (, PASC alone group). On average, the PASC alone group exhibited a "normal" peak exercise capacity, (89±18% predicted). ∼25% of patients had evidence of central cardiopulmonary pathology (, 12 with resting and exercise heart failure with preserved ejection fraction (HFpEF) and two with exercise pulmonary hypertension (PH)). PASC patients with HFpEF (, PASC HFpEF group) exhibited similarly impaired pEO with well compensated PH (, peak and CO >80% respectively) despite aberrant central cardiopulmonary exercise haemodynamics. PASC patients with HFpEF also exhibited increased body mass index of 39±7 kg·m. To examine the relative contribution of obesity to exertional impairment in PASC HFpEF, a control group comprising obese non-PASC group (n=61) derived from a historical iCPET cohort was used. The non-PASC obese patients with preserved peak (>80% predicted) exhibited a normal peak pulmonary artery wedge pressure (17±14 25±6 mmHg; p=0.03) with similar maximal voluntary ventilation (90±12 86±10% predicted; p=0.53) compared to PASC HFpEF patients. Impaired pEO was not significantly different between PASC patients who underwent supervised rehabilitation and those who did not (p=0.19).

CONCLUSIONS

This study highlights the importance of considering impaired pEO in PASC patients with persistent exertional intolerance unexplained by conventional investigative testing. Results of the current study also highlight the prevalence of a distinct high output HFpEF phenotype in PASC with a primary peripheral limitation to exercise.

摘要

背景

2019冠状病毒病(COVID-19)的急性后遗症(PASC)影响了很大一部分曾感染过严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的患者,运动不耐受是其突出症状。本研究旨在通过有创心肺运动试验(iCPET)来描述PASC相关运动不耐受的有创血流动力学异常。

研究设计与干预

从耶鲁大学COVID-19康复项目中招募了55名患者,大多数患者经历过轻度急性疾病。对所有参与者进行了仰卧位右心导管检查和iCPET。

主要结果

大多数(75%)PASC患者在iCPET期间表现出峰值全身氧摄取(pEO)受损,同时心输出量(CO)超常(,单纯PASC组)。平均而言,单纯PASC组表现出“正常”的峰值运动能力,(预测值为89±18%)。约25%的患者有中心心肺病理证据(,12例为静息和运动时射血分数保留的心力衰竭(HFpEF),2例为运动性肺动脉高压(PH))。尽管中心心肺运动血流动力学异常,但患有HFpEF的PASC患者(,PASC HFpEF组)表现出类似的pEO受损,且PH得到良好代偿(,峰值 和CO分别>80%)。患有HFpEF的PASC患者的体重指数也增加至39±7 kg·m。为了研究肥胖对PASC HFpEF运动损伤的相对影响,使用了一个由历史iCPET队列中的肥胖非PASC组(n = 61)组成的对照组。与PASC HFpEF患者相比,峰值 保留(>预测值80%)的非PASC肥胖患者表现出正常的峰值肺动脉楔压(17±14 25±6 mmHg;p = 0.03),最大自主通气量相似(90±12 86±10%预测值;p = 0.53)。接受监督康复的PASC患者和未接受监督康复的PASC患者之间的pEO受损无显著差异(p = 0.19)。

结论

本研究强调了在常规检查无法解释的持续性运动不耐受PASC患者中考虑pEO受损的重要性。本研究结果还突出了在PASC中一种独特的高输出HFpEF表型的患病率,其主要外周运动受限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/10860209/e8d98a7691f4/00714-2023.01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验